Bristol-Myers Squibb Company

Stock Chart, Company Information, and Scan Results

$45.95(as of Oct 31, 10:14 AM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Bristol-Myers Squibb Company Company Information, Fundamentals, and Technical Indicators

Stock Price$45.95
Ticker SymbolBMY
ExchangeNyse
SectorHealthcare
IndustryDrug Manufacturers - General
Employees34,100
CountyUSA
Market Cap$86,709.6M

BMY takes the fight against disease to the heart, with leading cardiovascular medications like Camzyos—an FDA-approved treatment for obstructive hypertrophic cardiomyopathy. The global biopharmaceutical company is also well-known for its development of oncology and immunology products, including Opdivo and Yervoy for cancer treatment, and Orencia for rheumatoid arthritis. If you are looking to add a well-diversified biopharmaceutical stock to your portfolio, BMY could be the one.

Bristol-Myers Squibb Company In Our Stock Scanner

As of Oct 31, 2025
As of ---
example chart graphic
Scan Name: Low PS RatioScan Type: Stock Fundamentals
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.